Scientific article
Open access

Sars-cov-2 inhibition by sulfonated compounds

Published inMicroorganisms
Publication date2020

Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) depends on angiotensin converting enzyme 2 (ACE2) for cellular entry, but it might also rely on attachment receptors such as heparan sulfates. Several groups have recently demonstrated an affinity of the SARS-CoV2 spike protein for heparan sulfates and a reduced binding to cells in the presence of heparin or heparinase treatment. Here, we investigated the inhibitory activity of several sulfated and sulfonated molecules, which prevent interaction with heparan sulfates, against vesicular stomatitis virus (VSV)-pseudotyped-SARS-CoV-2 and the authentic SARS-CoV-2. Sulfonated cyclodextrins and nanoparticles that have recently shown broad-spectrum non-toxic virucidal activity against many heparan sulfates binding viruses showed inhibitory activity in the micromolar and nanomolar ranges, respectively. In stark contrast with the mechanisms that these compounds present for these other viruses, the inhibition against SARS-CoV-2 was found to be simply reversible.

Citation (ISO format)
GASBARRI, Matteo et al. Sars-cov-2 inhibition by sulfonated compounds. In: Microorganisms, 2020. doi: 10.3390/microorganisms8121894
Main files (1)
Article (Published version)
Secondary files (1)
ISSN of the journal2076-2607

Technical informations

Creation11/30/2020 10:19:00 AM
First validation11/30/2020 10:19:00 AM
Update time03/15/2023 11:35:57 PM
Status update03/15/2023 11:35:56 PM
Last indexation02/12/2024 11:59:17 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack